TYK16 - Revision history

WikiSysop at 23:00, 22 January 2022

2022-01-22T23:00:58Z

← Older revision		Revision as of 23:00, 22 January 2022
Line 1:		Line 1:
	__NOTOC__		__NOTOC__
	~~<div class="mw-collapsible mw-collapsed" style="width:100%">~~
	Which of the following statements is true concerning aspirin?		Which of the following statements is true concerning aspirin?

Line 10:		Line 9:

	D. Aspirin's effects are reversible with administration of FFP		D. Aspirin's effects are reversible with administration of FFP
			<div class="mw-customtoggle-TYK_Answer" style="text-align: right; color:#0000ff">Click for Answer</div>
	<div class="mw-collapsible-~~content~~">		<div class="mw-collapsible mw-collapsed" id="mw-customcollapsible-TYK_Answer">



	==Answer==		==Answer==
	~~[[image:aspirin.gif\|right]]~~

	The answer is A. Aspirin's mechanism of action is the interference of synthesis of arachidonic acid. Inhibiting the P2Y12 purinergic receptor involved in platelet activation is the mechanism for clopidigrel (Plavix) and ticlopidine (Ticlid). Aspirin has effects that are IRREVERSIBLE and last longer than 24 hours. The effects of aspirin last for the life of the platelet (between 0-5 days depending on how old the platelet is already).		The answer is A. Aspirin's mechanism of action is the interference of synthesis of arachidonic acid. Inhibiting the P2Y12 purinergic receptor involved in platelet activation is the mechanism for clopidigrel (Plavix) and ticlopidine (Ticlid). Aspirin has effects that are IRREVERSIBLE and last longer than 24 hours. The effects of aspirin last for the life of the platelet (between 0-5 days depending on how old the platelet is already).



	==Notes==		==Notes==
	<references />		<references />



	==Keywords==		==Keywords==
Line 31:		Line 20:

	[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3531005/ Shahani Jagdish Menghraj. Anaesthetic considerations in children with congenital heart disease undergoing non-cardiac surgery. Indian J Anaesth. 2012 Sep-Oct; 56(5): 491–495.]		[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3531005/ Shahani Jagdish Menghraj. Anaesthetic considerations in children with congenital heart disease undergoing non-cardiac surgery. Indian J Anaesth. 2012 Sep-Oct; 56(5): 491–495.]
			</div>

	----		----
	----		----
	~~</div>~~


	<p style="text-align: center;">[[TYK15\|<Prev Question]] --- [[TYK17\|Next Question>]]</p>		<p style="text-align: center;">[[TYK15\|<Prev Question]] --- [[TYK17\|Next Question>]]</p>
	<p style="text-align: center;">[[TYK About \| About Test Your Knowledge]]</p>		<p style="text-align: center;">[[TYK About \| About Test Your Knowledge]]</p>

WikiSysop: 1 revision imported

2021-03-05T02:34:32Z

1 revision imported

← Older revision	Revision as of 02:34, 5 March 2021
(No difference)

metawikimedia>JustinHamrick at 16:10, 9 March 2015

2015-03-09T16:10:56Z

New page

__NOTOC__
<div class="mw-collapsible mw-collapsed" style="width:100%">
Which of the following statements is true concerning aspirin?

A. Aspirin interferes with the synthesis of arachidonic acid

B. Aspirin inhibits the P2Y12 purinergic receptor involved in platelet activation

C. Aspirin's effects last 12-24 hours

D. Aspirin's effects are reversible with administration of FFP

<div class="mw-collapsible-content">

==Answer==
[[image:aspirin.gif|right]]

The answer is A. Aspirin's mechanism of action is the interference of synthesis of arachidonic acid. Inhibiting the P2Y12 purinergic receptor involved in platelet activation is the mechanism for clopidigrel (Plavix) and ticlopidine (Ticlid). Aspirin has effects that are IRREVERSIBLE and last longer than 24 hours. The effects of aspirin last for the life of the platelet (between 0-5 days depending on how old the platelet is already).

==Notes==
<references />

==Keywords==
[http://www.eao.chups.jussieu.fr/polys/certifopt/saule_coxib/theme/1vane2003.pdf J.R. Vane*, R.M. Botting The mechanism of action of aspirin. Thrombosis Research 110 (2003) 255 – 258]

[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3531005/ Shahani Jagdish Menghraj. Anaesthetic considerations in children with congenital heart disease undergoing non-cardiac surgery. Indian J Anaesth. 2012 Sep-Oct; 56(5): 491–495.]

----
----
</div>

<p style="text-align: center;">[[TYK15|<Prev Question]] --- [[TYK17|Next Question>]]</p>
<p style="text-align: center;">[[TYK About | About Test Your Knowledge]]</p>